Athersys Inc. Stock
Your prediction
Athersys Inc. Stock
Our community identified positive and negative aspects for Athersys Inc. stock for the coming years. 2 users see the criterium "Worthwhile Investment for the next years" as a plus for the Athersys Inc. stock. On the other hand our users think that "Unique positioning" could be a problem in the future.
Pros and Cons of Athersys Inc. in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Athersys Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Athersys Inc. | - | - | - | - | - | - | - |
| Sangamo Therapeutics Inc. | -10.030% | -53.171% | -61.677% | -85.041% | -70.869% | -92.335% | -98.960% |
| Evolus Inc | 2.510% | 1.264% | 32.762% | -53.869% | -16.202% | -37.438% | -37.864% |
| Rhythm Pharmaceuticals | -1.430% | -5.479% | 2.985% | 22.124% | -26.203% | 289.831% | 298.844% |
Comments
Athersys, Inc. (NASDAQ: ATHX) is now covered by analysts at Alliance Global Partners. They set a "buy" rating on the stock.
Show more
Ratings data for ATHX provided by MarketBeat
